Type 2 diabetes mellitus (T2 DM ) is a chronic metabolic disorder characterized by hyperglycaemia, which can cause micro‐ and macrovascular complications. Chronic inflammation may be the cause and result of T2 DM , and its related complications as an imbalance between pro‐ and anti‐inflammatory cytokines can affect immune functions. Apart from genetic changes occurring within the body resulting in inflammation in T2 DM , epigenetic modifications can modify gene expression in response to environmental cues such as an unhealthy diet, lack of exercise and obesity. The most widely studied epigenetic modification, DNA methylation ( DNA m), regulates gene expression and may manipulate inflammatory genes to increase or decrease inflammation associated with T2 DM . This review explores the studies related to epigenetic changes, more specifically DNA m, associated with chronic inflammation in T2 DM , at both the cell and tissue levels. Studying epigenetic alterations during inflammatory response, as a result of genetic and environmental signals, creates opportunities for the development of “early detection/relative risk” tests to aid in prevention of T2 DM . Understanding inflammation in T2 DM at the gene level in inflammation‐associated cells and tissues may provide further insight for the development of specific therapeutic targets for the disorder.